San Diego, CA, United States of America

Susan Weinbach

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susan Weinbach: Innovator in Pharmaceutical Compositions

Introduction

Susan Weinbach is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 2 patents, her work focuses on enhancing the absorption of oligonucleotide drugs.

Latest Patents

Weinbach's latest patents include groundbreaking formulations. The first patent, titled "Antisense permeation enhancers," describes a pharmaceutical composition that combines an antisense oligonucleotide with a permeation enhancer. This enhancer features a multi-carbon backbone with functional groups and side chains, which facilitate drug delivery. The second patent, "Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption," outlines delayed release oral formulations. These formulations consist of two populations of carrier particles that enhance drug absorption at different locations in the intestine.

Career Highlights

Susan Weinbach is associated with Isis Pharmaceuticals, Inc., where she has been instrumental in advancing pharmaceutical technologies. Her innovative approaches have positioned her as a key figure in the industry, contributing to the development of effective drug delivery systems.

Collaborations

Throughout her career, Weinbach has collaborated with notable colleagues, including Lloyd G Tillman and Richard S Geary. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Susan Weinbach's contributions to pharmaceutical compositions and drug delivery systems highlight her role as an influential inventor. Her patents reflect her commitment to enhancing drug absorption and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…